Generating hypotheses by discovering implicit associations in the literature: A case report of a search for new potential therapeutic uses for thalidomide.

被引:108
作者
Weeber, M
Vos, R
Klein, H
de Jong-van den Berg, LTW
Aronson, AR
Molema, G
机构
[1] Univ Groningen, Int Drug Explorat, Dept Social Pharm & Pharmacoepidemiol, Groningen, Netherlands
[2] Lister Hill Natl Ctr Biomed Commun, Natl Lib Med, Bethesda, MD USA
[3] Univ Masstricht, Dept Hlth Eth & Philosophy, Hlth Res Inst, Maastricht, Netherlands
[4] Univ Groningen, Inst Drug Explorat, Med Biol Sect, Dept Pathol & Lab Med, Groningen, Netherlands
关键词
D O I
10.1197/jamia.M1158
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
The availability of scientific bibliographies through online databases provides a rich source of information for scientists to support their research. However, the risk of this pervasive availability is that an individual researcher may fail to find relevant information that is outside the direct scope of interest. Following Swanson's ABC model of disjoint but complementary structures in the biomedical literature, we have developed a discovery support tool to systematically analyze the scientific literature in order to generate novel and plausible hypotheses. In this case report, we employ the system to find potentially new target diseases for the drug thalidomide. We find solid bibliographic evidence suggesting that thalidomide might be useful for treating acute pancreatitis, chronic hepatitis C, Helicobacter pylori-induced gastritis, and myasthenia gravis. However, experimental and clinical evaluation is needed to validate these hypotheses and to assess the trade-off between therapeutic benefits and toxicities.
引用
收藏
页码:252 / 259
页数:8
相关论文
共 52 条
[1]  
Aronson AR, 2001, J AM MED INFORM ASSN, P17
[2]   Is pathogenic humoral autoimmunity a Th1 response? Lessons from (for) myasthenia gravis [J].
Balasa, B ;
Sarvetnick, N .
IMMUNOLOGY TODAY, 2000, 21 (01) :19-23
[3]   Cytokine production by CAPAN-1 and CAPAN-2 cell lines [J].
Blanchard, JA ;
Barve, S ;
Joshi-Barve, S ;
Talwalker, R ;
Gates, LK .
DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (05) :927-932
[4]   Review article: immunological determinants that may affect the Helicobacter pylori cancer risk [J].
Blanchard, TG ;
Czinn, SJ .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 :83-90
[5]  
Brown KS, 1997, SCIENTIST, V11, P1
[6]   Thalidomide: Current and potential clinical applications [J].
Calabrese, L ;
Fleischer, AB .
AMERICAN JOURNAL OF MEDICINE, 2000, 108 (06) :487-495
[7]  
Callard R, 1994, CYTOKINE FACTSBOOK
[8]  
CHARATAN F, 1998, BMJ-BRIT MED J, V316, P1111
[9]  
Corral LG, 1999, J IMMUNOL, V163, P380
[10]   THE EFFECT OF THALIDOMIDE ON EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS [J].
CRAIN, E ;
MCINTOSH, KR ;
GORDON, G ;
PESTRONK, A ;
DRACHMAN, DB .
JOURNAL OF AUTOIMMUNITY, 1989, 2 (02) :197-202